Viemed Executes Diversification Strategy With $26 Million Acquisition of Home Equipment Provider in Illinois

Earnings Conference Call Announcement: Viemed Healthcare, Inc. will host its Third Quarter 2025 Earnings Conference Call on November 6, 2025, at 11:00 a.m. ET, with participation options provided for interested parties.

Company Overview: Viemed is a national leader in in-home, technology-enabled post-acute respiratory care, offering services such as non-invasive ventilators and sleep therapy, focusing on efficient home treatment through clinical practitioners.

Q2 2025 Financial Performance: Viemed Healthcare reported a 14.7% year-over-year revenue increase to $63.1 million, slightly missing analyst expectations, while GAAP EPS rose 115.1% to $0.08 but also fell short of projections. The company raised its full-year revenue and Adjusted EBITDA guidance following the acquisition of Lehan’s Medical Equipment.

Growth and Strategic Focus: The company experienced significant growth in patient volumes across its services, particularly in ventilator and PAP therapy segments, while also expanding into new healthcare areas such as sleep therapy and women's health. Management is closely monitoring gross margin trends amid shifts in service mix and integration of recent acquisitions.

Financial Performance: Viemed Healthcare reported a 17% increase in net revenues to $59.1 million for Q1 2025, with net income rising 64% to $2.6 million and adjusted EBITDA increasing by 26% to $12.8 million compared to the same quarter last year.

Acquisition Plans: The company announced plans to acquire Lehan's Medical Equipment for $26 million, which is expected to enhance its offerings in respiratory care and women's health, although this acquisition's impact has not yet been included in the updated full-year guidance for 2025.

Acquisition Announcement: Viemed Healthcare, Inc. has announced a definitive agreement to acquire Lehan's Medical Equipment, a family-owned healthcare provider specializing in home medical equipment and women's health, for a base purchase price of $26 million.

Growth Strategy: The acquisition aims to enhance Viemed's product offerings, particularly in maternal health, while leveraging Lehan's established reputation and community engagement to drive growth in the post-acute respiratory healthcare market.

Amplify Energy Corp Update: Shares of Amplify Energy Corp rose 15.5% in pre-market trading after the company terminated its merger agreement with Juniper Capital.

Pre-Market Stock Movements: Several stocks experienced significant changes, with AGM Group Holdings rising 47% and Spruce Biosciences falling 39.1% due to a workforce reduction plan.